Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 296,701 | 280,413 | 28,476 | 1,711 | 0 |
| Cost of Goods | 193,660 | 165,677 | 2,595 | 213 | 0 |
| Gross Profit | 103,041 | 114,736 | 25,881 | 1,498 | N/A |
| Operating Expenses | 127,449 | 136,098 | 101,923 | 95,793 | 26,907 |
| Operating Income | -23,748 | -20,685 | -75,447 | -94,082 | -26,907 |
| Interest Expense | 909 | 20,130 | 0 | 94 | 439 |
| Other Income | 1,935 | 1,687 | 582 | 0 | 91 |
| Pre-tax Income | -22,722 | -39,128 | -74,865 | -94,176 | -27,255 |
| Net Income Continuous | -22,722 | -39,128 | -74,865 | -94,176 | -27,255 |
| Net Income | $-22,722 | $-39,128 | $-74,865 | $-94,176 | $-27,255 |
| EPS Basic Total Ops | -0.68 | -1.19 | -2.47 | -3.88 | -1.48 |
| EPS Basic Continuous Ops | -0.68 | -1.19 | -2.47 | -3.88 | -2.01 |
| EPS Diluted Total Ops | -0.68 | -1.19 | -2.47 | -3.88 | -1.48 |
| EPS Diluted Continuous Ops | -0.68 | -1.19 | -2.47 | -3.88 | -2.01 |
| EPS Diluted Before Non-Recurring Items | -0.68 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-8,265 | $90,223 | $-74,853 | $-93,427 | $-26,736 |